Receptor group

5-HT1 receptors

5 related receptors and the ligands measured at several of them.

Binding affinity (Kᵢ)

18 ligands measured at two or more members, human values in nM, strongest first. Select a value for its assay and source.

View
Ligand5-HT1A receptor5-HT1B receptor5-HT1D receptor5-HT1E receptor5-HT1F receptor
5-MeO-DMT
LSDnot measured
ETH-LADnot measured
AL-LADnot measured
Bufoteninnot measured
5-MeO-MiPTnot measured
2C-Bnot measured
2C-Enot measured
DMTnot measured
Psilocinnot measured
4-HO-METnot measured
Psilocybinnot measured
DOI
DOBnot measured
Mescalinenot measured
DOMnot measured
MDAnot measured
Methylonenot measurednot measurednot measured
2C-Pnot measurednot measurednot measurednot measured
2C-Inot measurednot measurednot measurednot measured
2C-Cnot measurednot measurednot measurednot measured
2C-Dnot measurednot measurednot measurednot measured
ALD-52not measurednot measurednot measurednot measured
6-APBnot measurednot measurednot measurednot measured
5-APBnot measurednot measurednot measurednot measured
4-FAnot measurednot measurednot measurednot measured
4-FMAnot measurednot measurednot measurednot measured
α-PVPnot measurednot measurednot measurednot measured
Amphetaminenot measurednot measurednot measurednot measured
Methamphetaminenot measurednot measurednot measurednot measured
5-MeO-DMT at 5-HT1A: Kᵢ 3.0 nM, other reports differ, Halberstadt et al. 20125-MeO-DMT at 5-HT1B: Kᵢ 23 nM, other reports differ, Boess et al. 19945-MeO-DMT at 5-HT1D: Kᵢ 2.3 nM, other reports differ, Halberstadt et al. 20125-MeO-DMT at 5-HT1E: Kᵢ 376 nM, Halberstadt et al. 20125-MeO-DMT at 5-HT1F: Kᵢ 37 nM, Adham et al. 1993LSD at 5-HT1A: Kᵢ 1.3 nM, other reports differ, Eshleman et al. 2013LSD at 5-HT1B: Kᵢ 21 nM, other reports differ, Jain et al. 2025LSD at 5-HT1D: Kᵢ 3.5 nM, Jain et al. 2025LSD at 5-HT1E: Kᵢ 130 nM, Jain et al. 2025ETH-LAD at 5-HT1A: Kᵢ 3.5 nM, Jain et al. 2025ETH-LAD at 5-HT1B: Kᵢ 32 nM, Jain et al. 2025ETH-LAD at 5-HT1D: Kᵢ 15 nM, Jain et al. 2025ETH-LAD at 5-HT1E: Kᵢ 85 nM, Jain et al. 2025AL-LAD at 5-HT1A: Kᵢ 6.0 nM, Jain et al. 2025AL-LAD at 5-HT1B: Kᵢ 280 nM, Jain et al. 2025AL-LAD at 5-HT1D: Kᵢ 78 nM, Jain et al. 2025AL-LAD at 5-HT1E: Kᵢ 480 nM, Jain et al. 2025Bufotenin at 5-HT1A: Kᵢ 8.3 nM, Jain et al. 2025Bufotenin at 5-HT1B: Kᵢ 59 nM, Jain et al. 2025Bufotenin at 5-HT1D: Kᵢ 22 nM, Jain et al. 2025Bufotenin at 5-HT1E: Kᵢ 25 nM, Jain et al. 20255-MeO-MiPT at 5-HT1A: Kᵢ 25 nM, other reports differ, Puigseslloses et al. 20245-MeO-MiPT at 5-HT1B: Kᵢ 728 nM, Glatfelter et al. 20245-MeO-MiPT at 5-HT1D: Kᵢ 103 nM, other reports differ, Glatfelter et al. 20245-MeO-MiPT at 5-HT1E: Kᵢ 3496 nM, Ray 20102C-B at 5-HT1A: Kᵢ 240 nM, Rickli et al. 20152C-B at 5-HT1B: Kᵢ 104 nM, Ray 20102C-B at 5-HT1D: Kᵢ 26 nM, Ray 20102C-B at 5-HT1E: Kᵢ 120 nM, Ray 20102C-E at 5-HT1A: Kᵢ 360 nM, other reports differ, Rickli et al. 20152C-E at 5-HT1B: Kᵢ 253 nM, Ray 20102C-E at 5-HT1D: Kᵢ 73 nM, Ray 20102C-E at 5-HT1E: Kᵢ 626 nM, Ray 2010DMT at 5-HT1A: Kᵢ 356 nM, other reports differ, Kozell et al. 2023DMT at 5-HT1B: Kᵢ 450 nM, Jain et al. 2025DMT at 5-HT1D: Kᵢ 93 nM, Ray 2010DMT at 5-HT1E: Kᵢ 380 nM, Jain et al. 2025Psilocin at 5-HT1A: Kᵢ 164 nM, other reports differ, Glatfelter et al. 2022Psilocin at 5-HT1B: Kᵢ 580 nM, other reports differ, Glatfelter et al. 2022Psilocin at 5-HT1D: Kᵢ 130 nM, other reports differ, Glatfelter et al. 2022Psilocin at 5-HT1E: Kᵢ 155 nM, other reports differ, Glatfelter et al. 20224-HO-MET at 5-HT1A: Kᵢ 950 nM, Kozell et al. 20234-HO-MET at 5-HT1B: Kᵢ 331 nM, Glatfelter et al. 20234-HO-MET at 5-HT1D: Kᵢ 197 nM, Glatfelter et al. 20234-HO-MET at 5-HT1E: Kᵢ 161 nM, Glatfelter et al. 2023Psilocybin at 5-HT1A: Kᵢ 5284 nM, Glatfelter et al. 2022Psilocybin at 5-HT1B: Kᵢ 4983 nM, Glatfelter et al. 2022Psilocybin at 5-HT1D: Kᵢ 186 nM, Glatfelter et al. 2022Psilocybin at 5-HT1E: Kᵢ 601 nM, Glatfelter et al. 2022DOI at 5-HT1A: Kᵢ 2219 nM, Ray 2010DOI at 5-HT1D: Kᵢ 607 nM, Glatfelter et al. 2022DOI at 5-HT1E: Kᵢ 713 nM, other reports differ, Glatfelter et al. 2022DOI at 5-HT1F: Kᵢ 1739 nM, Adham et al. 1993DOI at 5-HT1B: Kᵢ of 10 µM or weakerDOB at 5-HT1A: Kᵢ 2550 nM, Ray 2010DOB at 5-HT1B: Kᵢ 941 nM, Ray 2010DOB at 5-HT1D: Kᵢ 636 nM, Ray 2010DOB at 5-HT1E: Kᵢ 1427 nM, Ray 2010Mescaline at 5-HT1A: Kᵢ 4600 nM, Rickli et al. 2015Mescaline at 5-HT1D: Kᵢ 790 nM, Jain et al. 2025Mescaline at 5-HT1E: Kᵢ 5205 nM, Ray 2010Mescaline at 5-HT1B: Kᵢ of 10 µM or weakerDOM at 5-HT1A: Kᵢ 3660 nM, Eshleman et al. 2018DOM at 5-HT1D: Kᵢ 1400 nM, other reports differ, Jain et al. 2025DOM at 5-HT1E: Kᵢ 2800 nM, Jain et al. 2025DOM at 5-HT1B: Kᵢ of 10 µM or weakerMDA at 5-HT1A: Kᵢ 4900 nM, Rickli et al. 2015MDA at 5-HT1B: Kᵢ of 10 µM or weakerMDA at 5-HT1D: Kᵢ of 10 µM or weakerMDA at 5-HT1E: Kᵢ of 10 µM or weakerMethylone at 5-HT1D: Kᵢ 7400 nM, Jain et al. 2025Methylone at 5-HT1A: Kᵢ of 10 µM or weaker2C-P at 5-HT1A: Kᵢ 110 nM, Rickli et al. 20152C-I at 5-HT1A: Kᵢ 180 nM, other reports differ, Rickli et al. 20152C-C at 5-HT1A: Kᵢ 190 nM, other reports differ, Rickli et al. 20152C-D at 5-HT1A: Kᵢ 440 nM, other reports differ, Rickli et al. 2015ALD-52 at 5-HT1A: Kᵢ 1054 nM, Halberstadt et al. 20206-APB at 5-HT1A: Kᵢ 1500 nM, Rickli et al. 20155-APB at 5-HT1A: Kᵢ 3300 nM, Rickli et al. 20154-FA at 5-HT1A: Kᵢ 4400 nM, Rickli et al. 20154-FMA at 5-HT1A: Kᵢ 5000 nM, Rickli et al. 2015α-PVP at 5-HT1A: Kᵢ 5200 nM, Rickli et al. 2015Amphetamine at 5-HT1A: Kᵢ 6740 nM, Simmler et al. 2013Methamphetamine at 5-HT1A: Kᵢ 8070 nM, Simmler et al. 20135-HT1A receptor5-HT1A5-HT1B receptor5-HT1B5-HT1D receptor5-HT1D5-HT1E receptor5-HT1E5-HT1F receptor5-HT1F5-MeO-DMT, Kᵢ: 5-HT1A 3.0 nM, 5-HT1B 23 nM, 5-HT1D 2.3 nM, 5-HT1E 376 nM, 5-HT1F 37 nM5-MeO-DMTLSD, Kᵢ: 5-HT1A 1.3 nM, 5-HT1B 21 nM, 5-HT1D 3.5 nM, 5-HT1E 130 nMLSDETH-LAD, Kᵢ: 5-HT1A 3.5 nM, 5-HT1B 32 nM, 5-HT1D 15 nM, 5-HT1E 85 nMETH-LADAL-LAD, Kᵢ: 5-HT1A 6.0 nM, 5-HT1B 280 nM, 5-HT1D 78 nM, 5-HT1E 480 nMAL-LADBufotenin, Kᵢ: 5-HT1A 8.3 nM, 5-HT1B 59 nM, 5-HT1D 22 nM, 5-HT1E 25 nMBufotenin5-MeO-MiPT, Kᵢ: 5-HT1A 25 nM, 5-HT1B 728 nM, 5-HT1D 103 nM, 5-HT1E 3496 nM5-MeO-MiPT2C-B, Kᵢ: 5-HT1A 240 nM, 5-HT1B 104 nM, 5-HT1D 26 nM, 5-HT1E 120 nM2C-B2C-E, Kᵢ: 5-HT1A 360 nM, 5-HT1B 253 nM, 5-HT1D 73 nM, 5-HT1E 626 nM2C-EDMT, Kᵢ: 5-HT1A 356 nM, 5-HT1B 450 nM, 5-HT1D 93 nM, 5-HT1E 380 nMDMTPsilocin, Kᵢ: 5-HT1A 164 nM, 5-HT1B 580 nM, 5-HT1D 130 nM, 5-HT1E 155 nMPsilocin4-HO-MET, Kᵢ: 5-HT1A 950 nM, 5-HT1B 331 nM, 5-HT1D 197 nM, 5-HT1E 161 nM4-HO-METPsilocybin, Kᵢ: 5-HT1A 5284 nM, 5-HT1B 4983 nM, 5-HT1D 186 nM, 5-HT1E 601 nMPsilocybinDOI, Kᵢ: 5-HT1A 2219 nM, 5-HT1B 10 µM or weaker, 5-HT1D 607 nM, 5-HT1E 713 nM, 5-HT1F 1739 nMDOIDOB, Kᵢ: 5-HT1A 2550 nM, 5-HT1B 941 nM, 5-HT1D 636 nM, 5-HT1E 1427 nMDOBMescaline, Kᵢ: 5-HT1A 4600 nM, 5-HT1B 10 µM or weaker, 5-HT1D 790 nM, 5-HT1E 5205 nMMescalineDOM, Kᵢ: 5-HT1A 3660 nM, 5-HT1B 10 µM or weaker, 5-HT1D 1400 nM, 5-HT1E 2800 nMDOMMDA, Kᵢ: 5-HT1A 4900 nM, 5-HT1B 10 µM or weaker, 5-HT1D 10 µM or weaker, 5-HT1E 10 µM or weakerMDAMethylone, Kᵢ: 5-HT1A 10 µM or weaker, 5-HT1D 7400 nMMethylone2C-P, Kᵢ: 5-HT1A 110 nM2C-P2C-I, Kᵢ: 5-HT1A 180 nM2C-I2C-C, Kᵢ: 5-HT1A 190 nM2C-C2C-D, Kᵢ: 5-HT1A 440 nM2C-DALD-52, Kᵢ: 5-HT1A 1054 nMALD-526-APB, Kᵢ: 5-HT1A 1500 nM6-APB5-APB, Kᵢ: 5-HT1A 3300 nM5-APB4-FA, Kᵢ: 5-HT1A 4400 nM4-FA4-FMA, Kᵢ: 5-HT1A 5000 nM4-FMAα-PVP, Kᵢ: 5-HT1A 5200 nMα-PVPAmphetamine, Kᵢ: 5-HT1A 6740 nMAmphetamineMethamphetamine, Kᵢ: 5-HT1A 8070 nMMethamphetamine
stronger weaker other reports differ 10 µM or weaker (when shown)no line not measured or filtered out, not “inactive”

Lines connect each ligand to the members it has a displayed human Kᵢ at. The thicker and darker the line, the stronger the value. A ligand sits close to the members it binds most strongly and between those it binds about equally, so its position is only approximate. Select a ligand or a member to follow its lines, or a line to see its assay and source. The table view lists the same values.

stronger weaker≥ 10 µM measured, 10 µM or weakerempty not measured* other reports differ† source not traced to the original

Human values only. A cell shows the value displayed on the compound page, from one assay. Values from different assays are not directly interchangeable, and a value does not establish clinical potency or safety.